Patents by Inventor Yuliya Levintova

Yuliya Levintova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Vomiting and Nausea with Minimum Dose of Olanzapine
    Publication number: 20240009204
    Abstract: Kits, compositions, devices, and methods for administration of olanzapine are provided. Uses thereof to treat nausea and vomiting are also provided.
    Type: Application
    Filed: September 24, 2021
    Publication date: January 11, 2024
    Inventors: James Oliver, Fotios Plakogiannis, Tamanna Lather, Marina Borovinskaya, Nisarg Modi, Rod L. Hartwig, Yuliya Levintova
  • Transdermal Drug Delivery Systems for Administration of a Therapeutically Effective Amount of Lenalidomide and Other Immunomodulatory Agents
    Publication number: 20220395468
    Abstract: Transdermal drug delivery systems and methods of fabricating such systems are provided. The active pharmaceutical ingredient can be lenalidomide or other immunomodulatory agents. More particularly, the present invention is directed to improving the solubility of lenalidomide and other immunomodulatory imide compounds and improving the permeation of such compounds through the skin.
    Type: Application
    Filed: June 3, 2022
    Publication date: December 15, 2022
    Inventors: Fotios Plakogiannis, Rod L. Hartwig, Nisarg Modi, Tamanna Lather, Yuliya Levintova, Marina Borovinskaya, Arturo Serrano-Batista
  • Continuous delivery of lenalidomide and other immunomodulatory agents
    Patent number: 11197852
    Abstract: Provided are methods for continuously administering to a subject in need of treatment a formulation comprising an immunomodulatory imide compound. In some embodiments, the method are for use in treating multiple myeloma, transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes, mantle cell lymphoma, hematologic cancers, or solid tumor cancers.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: December 14, 2021
    Assignee: Starton Therapeutics, Inc.
    Inventors: Marina Borovinskaya, Fotios Plakogiannis, Nisarg Modi, Tamanna Lather, Rod L. Hartwig, James C. Oliver, Yuliya Levintova